https://www.ajmc.com/view/dr-joshua-sabari-on-burden-treatment-options-for-patients-with-kras-mutated-nsclc
0
0
9/28/22 at 8:43pm
Organization
Ajmc.com
42 words
0
Comments
Joshua Sabari, MD, a thoracic medical oncologist, Perlmutter Cancer Center, NYU Langone Health, discusses actionable mutations in advanced non–small cell lung cancer (NSCLC).
You are the first to view
Create an account
or login to join the discussion